ID   HBL-4 [Human Burkitt lymphoma]
AC   CVCL_4218
DR   BTO; BTO_0002526
DR   Wikidata; Q54881436
RX   PubMed=1309680;
RX   PubMed=9454894;
RX   PubMed=15028022;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: ~36 hours (PubMed=1309680).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
RX   PubMed=1309680; DOI=10.1002/1097-0142(19920201)69:3<763::AID-CNCR2820690325>3.0.CO;2-#;
RA   Abe M., Tasaki K., Tominaga K., Fukuhara S., Imai S., Osato T.,
RA   Wakasa H.;
RT   "Characterization and comparison of two newly established Epstein-Barr
RT   virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines.
RT   EBV-negative cell line with a low level of expression of ICAM-1
RT   molecule and EBV-positive cell line with a high level of expression of
RT   ICAM-1 molecule.";
RL   Cancer 69:763-771(1992).
//
RX   PubMed=9454894; DOI=10.3892/ijo.12.1.113;
RA   Akasaka T., Akasaka H., Ohno H.;
RT   "Polymerase chain reaction amplification of long DNA targets:
RT   application to analysis of chromosomal translocations in human B-cell
RT   tumors.";
RL   Int. J. Oncol. 12:113-121(1998).
//
RX   PubMed=15028022; DOI=10.1111/j.1440-1827.2004.01612.x;
RA   Kamimura K., Hojo H., Abe M.;
RT   "Characterization of expression of protein kinase C isozymes in human
RT   B-cell lymphoma: relationship between its expression and prognosis.";
RL   Pathol. Int. 54:224-230(2004).
//